ESR1 and breast cancer: Furthermore, ESR1-responsive enhancer hypomethylation is critical in the transition from normal epithelial cells to endocrine-responsive luminal-like BC, supporting the concept that dynamic epigenetic variations are pivotal in cancer evolution (12).